Status:

TERMINATED

ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

Lead Sponsor:

Exosome Diagnostics, Inc.

Conditions:

Prostate Cancer

Eligibility:

MALE

50+ years

Brief Summary

The study is designed to confirm the performance of the ExoDx Prostate test in prior negative biopsy patients now presenting for a repeat prostate biopsy. Note: ExoDx Prostate test results are collec...

Detailed Description

Primary Endpoint: Evaluate the correlation of the ExoDx Prostate test results with the outcome of prostate biopsies in a prior negative repeat biopsy patient cohort. Secondary Endpoints (exploratory...

Eligibility Criteria

Inclusion

  • 50+ years of age
  • Clinical suspicion for prostate cancer
  • Elevated Prostate-specific Antigen between 2.0-10 ng/ mL
  • At least one (1) prior negative prostate biopsy

Exclusion

  • Use of medications or hormones that are known to affect serum PSA levels within 3-6 months of study enrollment including 5-alpha-reductase inhibitors used in the treatment of an enlarged prostate gland (benign prostatic hyperplasia). Drugs in this class are finasteride (Proscar, Propecia) and dutasteride (Avodart).
  • Clinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.
  • History of prostate cancer.
  • History of invasive treatments for benign prostatic hypertrophy (BPH) or lower urinary track symptoms within 6 months of study enrollment.
  • No known hepatitis status (all types) and/or HIV documented in patient's medical record.
  • Patients with history of concurrent renal/bladder tumors.

Key Trial Info

Start Date :

March 15 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2021

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04357717

Start Date

March 15 2020

End Date

September 1 2021

Last Update

March 31 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Chesapeake Urology Research Associates

Baltimore, Maryland, United States, 21204

2

New Jersey Urology

Voorhees Township, New Jersey, United States, 08043